Antiviral effectiveness and safety of azvudine in hospitalized SARS‐CoV‐2 patients with pre‐existing chronic respiratory diseases: A multicenter, retrospective cohort study

Abstract Although azvudine has become a priority in the treatment of SARS‐CoV‐2, its effectiveness and safety among COVID‐19 patients who already have chronic respiratory diseases (CRDs) have not been sufficiently validated. A retrospective, multicenter cohort study involving 10 hospitals in Henan P...

全面介紹

書目詳細資料

Principais autores:	Junyi Sun, Mengzhao Yang, Daoke Yao, Yongjian Zhou, Xiaobo Hu, Guowu Qian, Yiqiang Yuan, Silin Li, Hong Luo, Shixi Zhang, Guangming Li, Donghua Zhang, Guotao Li, Yanyang Zhang, Xinjun Hu, Zujiang Yu, Guangying Cui, Zhigang Ren
格式:	Artigo
語言:	Inglês
出版:	Wiley 2025-04-01
叢編:	View
主題:	azvudine chronic respiratory diseases real world SARS‐CoV‐2
在線閱讀:	https://doi.org/10.1002/VIW.20240133
標簽:	添加標簽 沒有標簽, 成為第一個標記此記錄!